Minnesota FOIA #P010262906

Dendritic cell vaccine technology transfer and validation as a plaiform to develop new cancer immunotherapies

The Twin Cities government agency awarded a contract to MILL CREEK LIFE SCIENCES LLC for dendritic cell vaccine technology transfer and validation to develop new cancer immunotherapies, with a total obligated amount of $143,000. The purchase was made on November 2, 2023, and the vendor is based in Rochester, Minnesota, USA. The contract involves a single lot purchase, and the award is part of a research and development initiative. The primary OEM/vendor is MILL CREEK LIFE SCIENCES LLC, and the buyer is the Twin Cities government. No specific contacts or additional location details are provided beyond the vendor address. Likely competitors for similar awards could include biotech and pharmaceutical companies specializing in immunotherapy development.

Description

Dendritic cell vaccine technology transfer and validation as a plaiform to develop new cancer immunotherapies